Pegfilgrastim
2 NDCs across 2 manufacturers|0 Generic,2 Brand
Pegfilgrastim is used to treat neutropenia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $96 million on Pegfilgrastim across 14,000 claims for 4,336 beneficiaries.
Pegfilgrastim is available as 2 NDCs from 2 manufacturers (0 generic, 2 brand), with NADAC prices from $3185.94 to $10074.86 per ML — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
2
competing in market
Price Spread
$3185.94 – $10074.86
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
2 manufacturers producing PEGFILGRASTIM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NEULASTA 6 MG/0.6 ML SYRINGE | $10074.8571 per ML | — |
FULPHILA 6 MG/0.6 ML SYRINGE | $3185.9367 per ML | — |
Frequently Asked Questions
What is Pegfilgrastim used to treat?
Pegfilgrastim is used to treat neutropenia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Pegfilgrastim?
In 2024, Medicare Part D spent $96 million on Pegfilgrastim across 14,000 claims for 4,336 beneficiaries.
How many Pegfilgrastim products are on the market?
The Pegfilgrastim drug market contains 2 NDCs from 2 manufacturers — 0 generic and 2 brand products.
What is the price range for Pegfilgrastim?
NADAC reference prices for Pegfilgrastim range from $3185.9367 to $10074.8571 per ML — the most expensive product costs about 3.2× the cheapest.
Which manufacturers make Pegfilgrastim?
2 manufacturers list Pegfilgrastim in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (1), Mylan Institutional LLC (1).